{"transactions":[{"id":929937,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:02.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":30453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date."}],"balance_after":66453,"source":{"system":"sec-edgar","filing":"0001213900-26-008477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000121390026008477/ownership.xml","form_type":"4"}},{"id":1297450,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-22T21:09:45.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date."}],"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001213900-25-005673","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000121390025005673/ownership.xml","form_type":"4"}},{"id":1565903,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T16:26:58.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board."}],"balance_after":30000,"derivative":{"exercise_price":3.55,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899140-24-000325","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000089914024000325/form4.xml","form_type":"4"}},{"id":1886808,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-18T16:51:18.000Z","date":"2023-05-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.3735,"value":43735.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 17, 2023, the reporting person filed a Form 4 which inadvertently included Transaction Code \"A\". The original Form 4 should have indicated Transaction Code \"P\". The reporting person has filed this amendment to restate the transaction with the correct Transaction Code."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0000929638-23-001529","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000092963823001529/form4.xml","form_type":"4/A","original_submission_date":"2023-05-17"}},{"id":1888912,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-17T17:37:31.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":4.3735,"value":43735.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0000929638-23-001519","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000092963823001519/form4.xml","form_type":"4"}},{"id":1918948,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-04-17T16:06:27.000Z","date":"2023-04-13","kind":"grant","planned":false,"acquired":true,"shares":14200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on 04/13/2023 and are subject to monthly vesting in equal installments during the one-year period beginning on 05/23/2023, subject to continued service on the board of directors."}],"balance_after":14200,"derivative":{"exercise_price":5.25,"expiration_date":"2033-04-13","underlying":"Common Stock","underlying_shares":14200},"source":{"system":"sec-edgar","filing":"0000929638-23-001181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000092963823001181/form4.xml","form_type":"4"}},{"id":1918947,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-04-17T16:06:27.000Z","date":"2023-04-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on 04/13/2023. One-third of the options vested on the date of grant. One-third of the options will vest on each of the first and second anniversaries of the grant, subject to continued service on the board of directors."}],"balance_after":25000,"derivative":{"exercise_price":5.25,"expiration_date":"2033-04-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000929638-23-001181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000092963823001181/form4.xml","form_type":"4"}},{"id":3533704,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-05-09T21:43:25.000Z","date":"2019-05-07","kind":"exercise","acquired":false,"shares":83277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 333,111 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 333,111 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.  The restricted stock units do not expire."}],"balance_after":249834,"derivative":{"underlying":"Class A Common Stock","underlying_shares":83277},"source":{"system":"sec-edgar","filing":"0001723128-19-000088","document":"wf-form4_155743819080725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/wf-form4_155743819080725.xml","form_type":"4"}},{"id":3533703,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2019-05-09T21:43:25.000Z","date":"2019-05-07","kind":"tax_withholding","acquired":false,"shares":21609,"price":13.44,"value":290424.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":78668,"source":{"system":"sec-edgar","filing":"0001723128-19-000088","document":"wf-form4_155743819080725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/wf-form4_155743819080725.xml","form_type":"4"}},{"id":3533702,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2019-05-09T21:43:25.000Z","date":"2019-05-07","kind":"exercise","acquired":true,"shares":83277,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":100277,"source":{"system":"sec-edgar","filing":"0001723128-19-000088","document":"wf-form4_155743819080725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/wf-form4_155743819080725.xml","form_type":"4"}},{"id":3599511,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2019-03-12T20:49:25.000Z","date":"2019-03-12","kind":"purchase","acquired":true,"shares":17000,"price":11.92,"value":202640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $11.89 per share to $11.94 per share.  The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001723128-19-000042","document":"wf-form4_155242375114309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/wf-form4_155242375114309.xml","form_type":"4"}},{"id":3613230,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-03-05T23:04:23.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":197531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2020."}],"balance_after":197531,"derivative":{"underlying":"Class A Common Stock","underlying_shares":197531},"source":{"system":"sec-edgar","filing":"0001723128-19-000036","document":"wf-form4_155182704832666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000036/wf-form4_155182704832666.xml","form_type":"4"}},{"id":3613229,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2019-03-05T23:04:23.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":402212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on March 1, 2020."}],"balance_after":402212,"derivative":{"exercise_price":13.5,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":402212},"source":{"system":"sec-edgar","filing":"0001723128-19-000036","document":"wf-form4_155182704832666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000036/wf-form4_155182704832666.xml","form_type":"4"}},{"id":3941180,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2018-05-09T22:33:50.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":333111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":333111,"derivative":{"underlying":"Class A Common Stock","underlying_shares":333111},"source":{"system":"sec-edgar","filing":"0000899243-18-012150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012150/doc4.xml","form_type":"4"}},{"id":3941179,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2018-05-09T22:33:50.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":681199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":681199,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":681199},"source":{"system":"sec-edgar","filing":"0000899243-18-012150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318012150/doc4.xml","form_type":"4"}},{"id":4117109,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-01-02T16:41:06.000Z","date":"2017-12-29","kind":"tax_withholding","acquired":false,"shares":2149,"price":163.58,"value":351533.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":66650,"source":{"system":"sec-edgar","filing":"0001179110-18-000118","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911018000118/edgar.xml","form_type":"4"}},{"id":4178493,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Based Restricted Share Unit","published_at":"2017-10-30T21:22:48.000Z","date":"2017-10-26","kind":"exercise","acquired":false,"shares":12427,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12427},"source":{"system":"sec-edgar","filing":"0001179110-17-013552","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017013552/edgar.xml","form_type":"4"}},{"id":4178492,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-10-30T21:22:48.000Z","date":"2017-10-26","kind":"exercise","acquired":true,"shares":12427,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest in equal installments on each of December 31, 2017, December 31, 2018 and December 31, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Performance Based Restricted Share Unit or PSU represented a contingent right to receive a number of Ordinary Shares equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":68799,"source":{"system":"sec-edgar","filing":"0001179110-17-013552","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017013552/edgar.xml","form_type":"4"}},{"id":4361094,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-04-04T16:23:13.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":7362,"price":237.68,"value":1749800.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest twenty percent (20%) on April 3, 2018, twenty percent (20%) on April 3, 2019, twenty percent (20%) on April 3, 2020, twenty percent (20%) on April 3, 2021 and twenty percent (20%) on April 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":56372,"source":{"system":"sec-edgar","filing":"0001179110-17-005547","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017005547/edgar.xml","form_type":"4"}},{"id":4397390,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-03-07T16:54:04.000Z","date":"2017-03-05","kind":"tax_withholding","acquired":false,"shares":761,"price":245.63,"value":186924.43,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":49010,"source":{"system":"sec-edgar","filing":"0001179110-17-004108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017004108/edgar.xml","form_type":"4"}},{"id":4468630,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-02-03T19:56:58.000Z","date":"2017-02-01","kind":"exercise","acquired":true,"shares":2369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents performance-based restricted share units (\"PSUs\") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents performance-based restricted share units (\"PSUs\") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":229.32,"exercise_date":"2017-02-01","expiration_date":"2017-02-01","underlying":"Ordinary Shares","underlying_shares":2369},"source":{"system":"sec-edgar","filing":"0001179110-17-001724","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017001724/edgar.xml","form_type":"4"}},{"id":4468629,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-02-03T19:56:58.000Z","date":"2017-02-01","kind":"tax_withholding","acquired":false,"shares":798,"price":229.32,"value":182997.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":49771,"source":{"system":"sec-edgar","filing":"0001179110-17-001724","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017001724/edgar.xml","form_type":"4"}},{"id":4468628,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":68705,"kind":"person","name":"Stewart Robert A","position":1,"cik":"0001476493","reported_name":"Stewart Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-02-03T19:56:58.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":2369,"price":229.32,"value":543259.08,"ownership":{"direct":true},"balance_after":50569,"source":{"system":"sec-edgar","filing":"0001179110-17-001724","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476493/000117911017001724/edgar.xml","form_type":"4"}}]}